Citigroup
ANIP icon

Citigroup’s ANI Pharmaceuticals ANIP Stock Holding History

Citigroup’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$6K – 6220
2020
Q4 		$6K Sell
200
-400
-67% -$11.5K ﹤0.01% 7067
2020
Q3 		$17K Buy
600
+400
+200% +$11.9K ﹤0.01% 6287
2020
Q2 		$6K Sell
200
-1,500
-88% -$53.8K ﹤0.01% 7206
2020
Q1 		$69K Hold
1,700
– – ﹤0.01% 5666
2019
Q4 		$105K Buy
1,700
+1,400
+467% +$92.7K ﹤0.01% 5733
2019
Q3 		$22K Sell
300
-200
-40% -$15K ﹤0.01% 6668
2019
Q2 		$41K Buy
500
+400
+400% +$28.4K ﹤0.01% 6640
2019
Q1 		$7K Sell
100
-4,000
-98% -$235K ﹤0.01% 7329
2018
Q4 		$185K Sell
4,100
-200
-5% -$10.5K ﹤0.01% 5091
2018
Q3 		$243K Buy
4,300
+4,200
+4,200% +$257K ﹤0.01% 5044
2018
Q2 		$7K Buy
+100
New +$6.24K ﹤0.01% 7264
2018
Q1 		– Sell
-4,200
Closed -$271K – 7520
2017
Q4 		$271K Buy
4,200
+2,200
+110% +$137K ﹤0.01% 4756
2017
Q3 		$105K Sell
2,000
-2,000
-50% -$95.4K ﹤0.01% 5526
2017
Q2 		$187K Sell
4,000
-4,700
-54% -$227K ﹤0.01% 4855
2017
Q1 		$431K Buy
8,700
+2,000
+30% +$112K ﹤0.01% 3999
2016
Q4 		$406K Buy
6,700
+5,800
+644% +$355K ﹤0.01% 4597
2016
Q3 		$60K Buy
+900
New +$56.3K ﹤0.01% 5542

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citigroup's ANIP Position: Q1 2026 in Review

Citigroup reduced its ANI Pharmaceuticals (ANIP) stake by 16% in Q1 2026, selling an estimated $2.16M and leaving 144,281 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Citigroup first reported a position in ANIP in Q2 2013 and has held it in 49 quarters since. The position peaked at $13.6M in Q4 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Citigroup held 144,281 shares of ANI Pharmaceuticals worth $11.1M as of Q1 2026.
  • Citigroup sold 27,690 ANI Pharmaceuticals shares in Q1 2026, an estimated $2.16M.
  • ANI Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1407 holding.
  • Citigroup first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
  • Citigroup's ANI Pharmaceuticals position peaked at $13.6M in Q4 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.